ABSTRACT
Background Steroid hormones are essential signaling molecules in prostate cancer (PC). However, many studies focusing on liquid biomarkers fail to take hormonal status of these patients into account. Because steroid measurements are sensitive to bias caused by matrix effects, thus assessing potential matrix effects is an important step in combining ctDNA analysis with hormone status.
Methods We investigated the accuracy of multi-steroid hormone profiling in mechanically-separated plasma tubes (MSP) and in CellSave Preservative plasma tubes (CS), that are typically used to obtain ctDNA. We performed multiplex steroid profiling in samples obtained from ten healthy controls and ten castration-resistant prostate cancer patients
Results Steroid measurements were comparable between the MSP and serum tubes. A small but consistent decrease of 11 – 18% compared to serum was observed in CS tubes, which was considered to be within the acceptable margin. The minimally residual testosterone levels of castrate patients could be sensitively quantified in both CS and MSP samples.
Conclusions We validated the use of MSP and CS tubes for multi-steroid profiling by LC-MS/MS. The optimised use of these samples used in clinical trials will allow us to gain further insight into the steroid metabolism in PC patients.
Competing Interest Statement
M. P. L. is the recipient of grants of Sanofi, Johnson & Johnson and Astellas. Other authors did not declare a conflict of interests
Funding Statement
Funding for this project was provided by the Daniel den Hoed foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Medical ethical committee of the Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
General Abbreviations
- ANOVA
- Analysis of variance
- CRPC
- Castration resistant prostate cancer
- CS
- CellSave Preservative tube
- CTC
- Circulating tumour cell
- ctDNA
- circulating tumour DNA
- HC
- Healthy Control
- LOQ
- Limits of quantification
- MS
- Mass spectrometry
- MSP
- Mechanically separated plasma tube
- MTBE
- Methyl-tert butyl ether
- PC
- Prostate cancer
- S/N
- Signal-to-noise
- LC-MS/MS
- Liquid chromatography tandem mass spectrometry
- PBS-BSA
- phosphate-buffered saline with bovine serum albumin
Steroid abbreviations
- 17OHP
- 17-hydroxyprogesterone
- A4
- Androstenedione
- B
- Corticosterone
- DHEA
- Dehydroepiandrosterone
- DHT
- Dihydrotestosterone
- E
- Cortisone
- F
- Cortisol
- T
- Testosterone
